These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38925807)

  • 1. SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism
    Zhang Y; Niu X; Wang Y; Bao S; Jiang P; Dong X
    Anticancer Res; 2024 Jul; 44(7):2861-2870. PubMed ID: 38925807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma.
    Jeong SM; Lee A; Lee J; Haigis MC
    J Biol Chem; 2014 Feb; 289(7):4135-44. PubMed ID: 24368766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PIK3CA-E545K-SIRT4 signaling axis reduces radiosensitivity by promoting glutamine metabolism in cervical cancer.
    Jiang W; Ouyang X; Ji Z; Shi W; Wu Y; Yao Q; Wang Y; Yang W; Xiang L; Yang H
    Cancer Lett; 2023 Mar; 556():216064. PubMed ID: 36646410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism.
    Cai G; Ge Z; Xu Y; Cai L; Sun P; Huang G
    Sci Rep; 2022 Jul; 12(1):12208. PubMed ID: 35842463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PBK promotes aggressive phenotypes of cervical cancer through ERK/c-Myc signaling pathway.
    Ma H; Han F; Yan X; Qi G; Li Y; Li R; Yan S; Yuan C; Song K; Kong B
    J Cell Physiol; 2021 Apr; 236(4):2767-2781. PubMed ID: 33184870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Myc Overexpression Promotes Oral Cancer Cell Proliferation and Migration by Enhancing Glutaminase and Glutamine Synthetase Activity.
    Wang T; Cai B; Ding M; Su Z; Liu Y; Shen L
    Am J Med Sci; 2019 Sep; 358(3):235-242. PubMed ID: 31324362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
    Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT4 is the molecular switch mediating cellular proliferation in colorectal cancer through GLS mediated activation of AKT/GSK3β/CyclinD1 pathway.
    Cui Y; Bai Y; Yang J; Yao Y; Zhang C; Liu C; Shi J; Li Q; Zhang J; Lu X; Zhang Y
    Carcinogenesis; 2021 Apr; 42(3):481-492. PubMed ID: 33315089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
    Mukha A; Kahya U; Linge A; Chen O; Löck S; Lukiyanchuk V; Richter S; Alves TC; Peitzsch M; Telychko V; Skvortsov S; Negro G; Aschenbrenner B; Skvortsova II; Mirtschink P; Lohaus F; Hölscher T; Neubauer H; Rivandi M; Labitzky V; Lange T; Franken A; Behrens B; Stoecklein NH; Toma M; Sommer U; Zschaeck S; Rehm M; Eisenhofer G; Schwager C; Abdollahi A; Groeben C; Kunz-Schughart LA; Baretton GB; Baumann M; Krause M; Peitzsch C; Dubrovska A
    Theranostics; 2021; 11(16):7844-7868. PubMed ID: 34335968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEK-ERK (Raf/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase) pathway.
    Kim EJ; Juhnn YS
    J Biol Chem; 2015 Apr; 290(15):9604-13. PubMed ID: 25713071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT4 enhances the sensitivity of ER-positive breast cancer to tamoxifen by inhibiting the IL-6/STAT3 signal pathway.
    Xing J; Li J; Fu L; Gai J; Guan J; Li Q
    Cancer Med; 2019 Nov; 8(16):7086-7097. PubMed ID: 31573734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Targeting of the GLS1-c-Myc Positive Feedback Loop Suppresses Glutaminolysis and Inhibits Progression of Head and Neck Cancer.
    Yang J; Chen F; Lang L; Yang F; Fu Z; Martinez J; Cho A; Saba NF; Teng Y
    Cancer Res; 2024 Oct; 84(19):3223-3234. PubMed ID: 39024547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of SIRT4 promotes the self-renewal of Breast Cancer Stem Cells.
    Du L; Liu X; Ren Y; Li J; Li P; Jiao Q; Meng P; Wang F; Wang Y; Wang YS; Wang C
    Theranostics; 2020; 10(21):9458-9476. PubMed ID: 32863939
    [No Abstract]   [Full Text] [Related]  

  • 15. Serinc2 Drives the Progression of Cervical Cancer Through Regulating Myc Pathway.
    Wang X; Jiang C; Li Q
    Cancer Med; 2024 Oct; 13(19):e70296. PubMed ID: 39417376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of PFKFB4 induces cell cycle arrest and glucose metabolism inhibition by inactivating MEK/ERK/c-Myc pathway in cervical cancer cells.
    Wu Y; Zhang L; Bao Y; Wan B; Shu D; Luo T; He Z
    J Obstet Gynaecol; 2022 Aug; 42(6):2399-2405. PubMed ID: 35659173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Warburg Mechanism of Ginsenoside F2 in Human Cervical Cancer Cells via Activation of miR193a-5p and Inhibition of β-Catenin/c-Myc/Hexokinase 2 Signaling Axis.
    Shin N; Lee HJ; Sim DY; Ahn CH; Park SY; Koh W; Khil J; Shim BS; Kim B; Kim SH
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of SIRT4 Expression Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma.
    Nakahara Y; Yamasaki M; Sawada G; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mimori K; Mori M; Doki Y
    Oncology; 2016; 90(6):347-55. PubMed ID: 27082627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3 Regulates the Translation of Oncogene Myc through m
    Ma Y; Shi H; Zheng W
    Discov Med; 2024 Sep; 36(188):1902-1910. PubMed ID: 39327253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT4 inhibits malignancy progression of NSCLCs, through mitochondrial dynamics mediated by the ERK-Drp1 pathway.
    Fu L; Dong Q; He J; Wang X; Xing J; Wang E; Qiu X; Li Q
    Oncogene; 2017 May; 36(19):2724-2736. PubMed ID: 27941873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.